Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

WCGC 14

27 - 30 Jun 2012
Videos
Gastric cancer in Japan
Dr Takeshi Sano - National Cancer Centre Hospital, Tokyo, Japan
Gastric cancer in Japan ( Dr Takeshi Sano - National Cancer Centre Hospital, Tokyo, Japan )
23 Jul 2012
Genetic signatures for colon cancer
Prof Pierre Laurent-Puig - University of Paris, France
Genetic signatures for colon cancer ( Prof Pierre Laurent-Puig - University of Paris, France )
23 Jul 2012
An improving outlook for liver cancer patients
Dr Graeme Poston - University Hospital Aintree, Liverpool, UK
An improving outlook for liver cancer patients ( Dr Graeme Poston - University Hospital Aintree, Liverpool, UK )
23 Jul 2012
Colorectal cancer in the elderly
Dr Demetris Papamichael - BO Cyprus Oncology Centre, Nicosia, Cyprus
Colorectal cancer in the elderly ( Dr Demetris Papamichael - BO Cyprus Oncology Centre, Nicosia, Cyprus )
23 Jul 2012
The EUREKA Initiative
Prof Cornelius van de Velde - Leiden University Medical Center, Netherlands
The EUREKA Initiative ( Prof Cornelius van de Velde - Leiden University Medical Center, Netherlands )
23 Jul 2012
Neuroendocrine tumours of the pancreas
Prof Aurel Perren - University of Bern, Switzerland
Neuroendocrine tumours of the pancreas ( Prof Aurel Perren - University of Bern, Switzerland )
23 Jul 2012
Prevention best ‘treatment’ for colon cancer
Prof Nadir Arber – Integrated Cancer Prevention Center, Tel Aviv Medical Center...
Prevention best ‘treatment’ for colon cancer ( Prof Nadir Arber – Integrated Cancer Prevention Center, Tel Aviv Medical Center, Israel )
20 Jul 2012
Bevacizumab benefits beyond progression in TML study subgroups
Dr Thierry André – Hôpital Saint Antoine, Paris, France
Bevacizumab benefits beyond progression in TML study subgroups ( Dr Thierry André – Hôpital Saint Antoine, Paris, France )
17 Jul 2012
Pharmacodynamic endpoints need to be included in GI trials
Prof Fortunato Ciardiello – Seconda Università degli Studi di Napoli, Italy
Pharmacodynamic endpoints need to be included in GI trials ( Prof Fortunato Ciardiello – Seconda Università degli Studi di Napoli, Italy )
17 Jul 2012
Exploring new targets in GI cancer
Prof Josep Tabernero – Vall d’Hebron Institute of Oncology (VHIO), Barcelona...
Exploring new targets in GI cancer ( Prof Josep Tabernero – Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain )
17 Jul 2012
Unravelling mechanisms of resistance to targeted drugs
Prof Salvatore Siena – Niguarda Ca’ Granda Hospital, Milan, Italy
Unravelling mechanisms of resistance to targeted drugs ( Prof Salvatore Siena – Niguarda Ca’ Granda Hospital, Milan, Italy )
17 Jul 2012
CORRECT study data prompts US FDA priority review
Prof Alberto Sobrero – Ospedale San Martino, Genova, Italy
CORRECT study data prompts US FDA priority review ( Prof Alberto Sobrero – Ospedale San Martino, Genova, Italy )
17 Jul 2012
Anti-angiogenic trials; key highlights of the 14th WCGC
Prof Eric Van Cutsem – University Hospital Leuven, Gasthuisberg, Belgium
Anti-angiogenic trials; key highlights of the 14th WCGC ( Prof Eric Van Cutsem – University Hospital Leuven, Gasthuisberg, Belgium )
17 Jul 2012
Perifosine disappoints in refractory mCRC
Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA
Perifosine disappoints in refractory mCRC ( Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA )
16 Jul 2012
Screening and specialist nurses central to patient care
Jola Gore-Booth – EuropaColon, France / UK
Screening and specialist nurses central to patient care ( Jola Gore-Booth – EuropaColon, France / UK )
16 Jul 2012
Tivantinib first drug to have overall survival benefit as second-line...
Dr Camillo Porta – Fondazione IRCCS Policlinico Universitario San Matteo, Pavia...
Tivantinib first drug to have overall survival benefit as second-line hepatocellular carcinoma treatment ( Dr Camillo Porta – Fondazione IRCCS Policlinico Universitario San Matteo, Pavia, Italy )
16 Jul 2012
Adjuvant cetuximab disappoints again in mCRC
Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France
Adjuvant cetuximab disappoints again in mCRC ( Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France )
16 Jul 2012
Young Voices United against CRC
Dr Dino Tarabar – Military Medical Academy, Belgrade, Serbia
Young Voices United against CRC ( Dr Dino Tarabar – Military Medical Academy, Belgrade, Serbia )
16 Jul 2012
Advances in radiotherapy for rectal cancer
Dr Karin Haustermans – University Hospital Leuven, Belgium
Advances in radiotherapy for rectal cancer ( Dr Karin Haustermans – University Hospital Leuven, Belgium )
16 Jul 2012
Important to support young medical oncologists’ research
Prof Roberto Labianca – Riuniti Hospital, Bergamo, Italy
Important to support young medical oncologists’ research ( Prof Roberto Labianca – Riuniti Hospital, Bergamo, Italy )
16 Jul 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation